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Available online 8 October 2010Abstract Induced pluripotent stem cells (iPSCs) are generated by directly reprogramming somatic cells by forcing them to
express the exogenous transcription factors, Oct4, Sox2, Klf4 and c-Myc (OSKM). These cells could potentially be used in clinical
applications and basic research. Here, we explored the molecular role of Sox2 by generating iPSCs that expressed Sox2 at
various levels. Low Sox2 (LS) expression increased the efficiency of generating partially reprogrammed iPSCs in combination
with OKM. Notably, we detected a significant increase in the number of fully reprogrammed iPSCs with three factors of OK and
LS. LS expression was linked with the reduced expression of ectoderm and mesoderm marker genes. This indicates that cell
differentiation into the ectoderm and mesoderm lineages was impeded during reprogramming. The quality of the iPSCs that was
generated by using OK and LS was comparable to that of iPSCs that were produced via conventional OSK as seen by pluripotent
marker gene expression and chimera formation. We conclude that Sox2 plays a crucial role in a dose-dependent manner in
direct reprogramming of somatic cells to iPSCs.
© 2010 Elsevier B.V. All rights reserved.Introduction
Reprogramming somatic cells into pluripotent embryonic
stem cell (ESC)-like cells is achieved by the transduction
using a defined set of transcription factors: Oct4 (Pou5f1),
Sox2, Klf4 and c-Myc (OSKM) (Takahashi and Yamanaka,
2006; Hochedlinger and Plath, 2009). Induced pluripotent
stem cells (iPSCs) can also be established in the absence of a
transduced c-Myc (OSK) (Nakagawa et al., 2008) or by using⁎ Corresponding author. Laboratory of Stem Cell Engineering, Stem
Cell Research Center, Institute for Frontier Medical Sciences, Kyoto
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doi:10.1016/j.scr.2010.09.004other combinations of factors (Feng et al., 2009; Heng et al.,
2010). Although the generating iPSCs is technically simple
and ethically acceptable, transgene integration is problem-
atic for clinical applications. Recently, several groups have
reported on the generating iPSCs without having to use viral
vectors (Zhou et al., 2009; Kim et al., 2009). However, a
major issue with their approaches is the low efficiency of
producing iPSCs. Uncovering the function of reprogramming
factors would be helpful for improving the efficiency of
direct reprogramming.
Two reprogramming factors, Oct4 and Sox2, are core
regulatory factors that function cooperatively with Nanog in
both human and mouse ESCs (Boyer et al., 2005; Loh et al.,
2006). Oct4 has been studied at length and is recognized as
being essential for the early development and maintenance of.
178 S. Yamaguchi et al.pluripotency.Oct4-deficient embryos fail to form an inner cell
mass (Nichols et al., 1998). Reduced Oct4 expression in ESCs
causes them to differentiate into the trophectoderm, while
doubly high expression induces differentiation into the
primitive endoderm and mesoderm (Niwa et al., 2000). Sox2,
which is a high-mobility group DNA-binding domain transcrip-
tion factor, is also essential for early embryogenesis in mice
(Avilion et al., 2003). The twenty genes that comprise the
mouse Sox-family are classified into ten subgroups, whereby
Sox2 is categorized into group B1 (Schepers et al., 2002). Sox2
could be substituted for using Sox1 or Sox3 to generate iPSCs
(Nakagawa et al., 2008), even if low expression of these two
genes occurs in ESCs. Sox2 is expressed in the developing
central nervous system and maintains the properties of neural
precursor cells (Pevny and Nicolis, 2010). Oct4 and Sox2
cooperatively bind to and activate the transcription of genes
that bear Octamer and Sox elements, such as Oct4, Sox2,
Nanog, Fgf4,Utf1 and Lefty1 (Okumura-Nakanishi et al., 2005;
Tomioka et al., 2002; Kuroda et al., 2005; Johnson et al., 1998;
Nishimoto et al., 1999; Nakatake et al., 2006). Similar toOct4,
Sox2depletion and overexpression promotes differentiation. A
two-fold or less increase in Sox2 reduces the transcription of
Oct4/Sox2 target genes in ESCs. This results in differentiation
into various lineages, including the ectoderm and mesoderm
(Boer et al., 2007; Kopp et al., 2008; Adachi et al., 2010),while
the knockdown of Sox2 induces differentiation into endoderm
and trophectoderm lineages (Adachi et al., 2010; Chew et al.,
2005; Fong et al., 2008). Therefore, precisely regulating the
expression of the transcription factors is crucial to maintain
the pluripotent state of ESCs. However, the effects of
quantitative changes in reprogramming factors when inducing
pluripotent stem cells remain poorly understood.
Here, we examined the suppressive effects of excessive
Sox2 on direct reprogramming. Decreased Sox2 virus led to a
marked increase in the number of Oct4-GFP-positive cells.
However, resulting cell fates were different depending on
whether the transduction occurred with or without c-Myc
(OSKM and OSK). For OKM and reduced Sox2, the majority of
the GFP-positive colonies was trapped in a partially repro-
grammed state, while for OK and reduced Sox2, most of the
cells turned into fully reprogrammed iPSCs. A significant
increase in the number of differentiation markers, which
depended on the level of Sox2, was indicative that excessive
Sox2 expression promotes differentiation into the mesoderm
or ectoderm in parallel with reprogramming. Thus, our data is
supportive that the appropriate expression of Sox2 is critical
for efficiently generating iPSCs.Figure 1 Expression of Sox2 in virus dilution series. The
expression of Sox2, Oct4, and β-Actin (control) in mouse
embryonic fibroblasts on day 3 after OSKM (Oct4; Sox2; Klf4;
c-Myc) or OSK infection was analyzed by using Western blotting
hybridization. The ratio of the band intensity of Sox2 or Oct4 to
β–Actin was calculated using Image J software (NIH).Results
Expression control through the amount of virus
To investigate the effect of Sox2 expression on the
reprogramming process, mouse embryonic fibroblasts
(MEFs) were infected with various amounts of Sox2 virus.
We used two lines of experiments, one experiment which
utilized the mock virus (the empty retroviral pMX vector),
and the other which did not, to acess the efficiency of viral
infection. The results of quantitative Western blotting
analysis were indicative that the amount of Sox2 protein
corresponded to the amount of Sox2 virus that was present inOSKM and OSK during viral infection (Fig. 1). Interestingly, no
obvious difference in Sox2 expression was detected between
the experiment that entailed using the mock virus and that
which did not. Furthermore, an increase in Sox2 to 200%
resulted in a decrease in Oct4 (Fig. 1). This is suggestive that
excessive viral Oct4 and Sox2 proteins interacted with one
another during transcription, translation or degradation
regulation. It is possible that this Oct4 and Sox2 interaction
may conceal the difference in the total amount of virus
between the experiments that used the mock virus compared
to which did not. Therefore, we performed OSKM and OSK
infection without mock virus.
179Negative effects of excess Sox2 on reprogrammingReprogramming by OKM plus low Sox2
MEFs from Oct4-GFP ⁄ Neo-LacZ (Rosa26) double-transgenic
mouse embryos were prepared to evaluate the efficiency of
reprogramming. GFP expression is driven by the Oct4
promoter (Yoshimizu et al., 1999), while LacZ is ubiquitously
expressed in the double-transgenic cell (Friedrich and
Soriano, 1991). MEFs were split into several groups and
infected with OSKM at various concentrations of Sox2 virus.
Kinetic analysis of GFP-positive cells on days 6, 8 and 10 after
infection was indicative that the increased reprogramming
efficiencywasmost effective at the 20% Sox2 (LS) (Fig. 2A, B).Figure 2 Increase in the number of Oct4-GFP-positive cells for dir
Sox2 at low expression level (LS). (A) GFP-positive iPSC colonies on
20%). The colonies are encircled by dotted lines. (B) Kinetic analys
error bars that indicate S.E.M are hidden in the graph. 200% Sox2, S.E
Sox2, S.E.M.=±0.0 (day 4), ±0.8 (day 6), ±11.8 (day 8), ±14.1 (day 1
±22.5 (day 10); 20% Sox2, S.E.M.=0.0 (day 4), ±3.8 (day 6), ±17.8
(day 6), ±19.9 (day 8), ±16.5 (day 10); 0% Sox2; S.E.M.=±0.0 (day 4
frequency of fully reprogrammed iPSCs by OSKM and OKM+LS transd
colonies with OSK. The error bars that indicate S.E.M are hidden in t
(day 12), ±0.1 (day 14), ±0.5 (day 16); 100% Sox2, S.E.M.=±0.0 (da
50% Sox2, S.E.M.=±0.0 (day 8), ±1.3 (day 10), ±3.7 (day 12), ±10.
(day 10), ±3.3 (day 12), ±6.6 (day 14), ±8.0 (day 16); 10% Sox2, S.E.M
(day 16); 0% Sox2, S.E.M.=±0.0 (day 8), ±0.0 (day 10), ±0.0 (day 12
fully reprogrammed iPSCs by OSK and OK+LS transduction.The number of GFP-positive cells had increased about five
times for OKM and LS (OKM+LS) when compared to
conventional OSKM by using fluorescence-activated cell
sorting (FACS) analysis (Supplementary Fig. 2A). For 10%
and 200% Sox2, the reprogramming efficiency decreased
compared to conventional OSKM on day 10 (Fig. 2B). To
examine whether the increase of GFP-positive cells improved
the generation efficiency to fully reprogrammed iPSCs, which
were defined by the stable GFP expression and maintenance
of undifferentiated state, each GFP-positive clone that was
picked up was cultured for a month. Notably, fifteen fully
reprogrammed clones were established out of seventy-twoect reprogramming by using OKM (Oct4; Klf4; c-Myc) or OK with
day 10 after infection of OSKM (Sox2 100%) and OKM+LS (Sox2
is of the number of Oct4-GFP-positive colonies with OSKM. The
.M.=±0.0 (day 4), ±0.0 (day 6), ±3.6 (day 8), ±4.0 (day10); 100%
0); 50% Sox2, S.E.M.=±0.0 (day 4), ±3.1 (day 6), ±18.7 (day 8),
(day 8), ±28.0 (day 10); 10% Sox2, S.E.M.=±0.0 (day 4), ±3.7
), ±0.0 (day 6), ±0.9 (day 8), ±0.2 (day 10). (C) The generation
uction. (D) Kinetic analysis of the number of Oct4-GFP-positive
he graph. 200% Sox2, S.E.M.=±0.0 (day 8), ±0.0 (day 10), ±±0.0
y 8), ±0.5 (day 10), ±1.2 (day 12), ±2.6 (day 14), ±4.8 (day 16);
7 (day 14), ±8.3 (day 16); 20% Sox2, S.E.M.=0.0 (day 8), ±1.1
.=±0.0 (day 8), ±0.6 (day 10), ±2.2 (day 12), ±4.8 (day 14), ±4.2
), ±0.0 (day 14), ±0.1 (day 16). (E) The generation frequency of
180 S. Yamaguchi et al.clones (20.8%) for conventional OSKM, while nine out of
ninety-two clones (9.4%) were established for OKM+LS
(Fig. 2C). The OKM+LS infection resulted in a prominent
increase in GFP-positive partially reprogrammed iPSCs.
However, there was no significant increase in the number
of fully reprogrammed iPSCs. In total, the reprogramming
efficiency for MEFs being changed into fully reprogrammed
iPSCs was not significantly improved.
The expression of lineage and pluripotent marker genes
was then examined using quantitative reverse transcription-
PCR (qPCR) to characterize differentiating cells and GFP-
positive cells that were generated by reprogramming with
OKM+LS. For pluripotent marker genes, Fgf4, Utf1, Rex1,
Eras and Sall4 expression was high for OKM+LS rather than
for OSKM (Supplementary Fig. 1A-C). For the lineage marker
genes, mesoderm marker expression including that of Flk1,
Gremlin and Myh2, and ectoderm marker expression
including that of Nestin, Sox13, Sox21 and CryM was
significantly low for OKM+LS compared to OSKM on day 3
(Supplementary Fig. 1D). However, the expression of
endoderm and trophectoderm makers was not. A similar
situation was noted for on days 7 and 12 after infection
(Supplementary Fig. 1E). Notably, partially reprogrammed
iPSCs in OKM+LS (Supplementary Fig. 2B) were character-
ized as having low expression of Sox2, Nanog and Fgf4, and
high c-Myc, Sox17 and Desmin expression (Supplementary
Fig. 2C). Taking these findings into consideration, excessive
Sox2 expression for conventional OSKM induces differentia-
tion of reprogramming cells into the ectoderm and meso-
derm lineages, at least in part, in a Sox2-dependent manner.
Three fully reprogrammed OKM+LS iPSC lines (#1~#3)
that were characterized using Oct4-GFP expression (Sup-
plementary Fig.3A), pluripotent marker gene expression
(Supplementary Fig. 3B), and pluripotent marker protein
expression (Supplementary Fig. 3C) were pluripotent. This
was revealed by contribution to the three primary layers and
germ cells of an E12.5 chimeric embryo, for which two
chimeras out of five embryos were obtained with the #2 iPSC
line (Supplementary Fig. 3D).Reprogramming by OK plus low Sox2
The improved reprogramming efficiency for changing MEFs
into fully reprogrammed iPSCs was unclear with OKM+LS.
Therefore, we examined the reprogramming efficiency in
OK and various concentrations of Sox2 to exclude the effect
of c-Myc. The number of GFP-positive colonies with Sox2 at
200%, 100%, 50%, 20% and 10% was counted (Fig. 2D).
Excessive (200%) and extremely low (10%) Sox2 resulted in no
significant improvement in the reprogramming efficiency.
For OK+20% Sox2 (LS), the number of GFP-positive colonies
was 3.3 times higher than for OSK on day 10 of infection.
Notably, a similar tendency was detected consecutively on
days 12, 14 and 16 (Fig. 2D). The rate for establishing fully
reprogrammed iPSCs for OK+LS at 57% was comparable to
that for conventional OSK at 52% (Fig. 2E). No increase in
the number of partially reprogrammed cells was observed
for OK+LS (data not shown). Taking these findings into
consideration together, the net generation efficiency of fully
reprogrammed iPSCs for OK+LS infection was approximately
three times higher than for conventional OSK infection.Alternative cell fates induced by OK plus LS
Pluripotent and lineage marker gene expression was ana-
lyzed using qPCR on day 3 after infection to explore the cell
fate on reprogramming by using OK+LS. Among the
pluripotent marker genes, expression of the reprogramming
factors, total Oct4 and Klf4, was markedly high, while that
for total Sox2 was low for OK+LS (Fig. 3A). The Oct4/Sox2
target genes, Nanog, Lefty1, Fgf4 and Utf1 were highly
expressed for OK+LS (Fig. 3B). In particular, Fgf4 expression
was about seven times higher for OK+LS than for OSK. For
other pluripotent markers, Rex1, Eras, Sall4 and Ronin were
highly expressed for OK+LS (Fig. 3C).
Among the lineage marker gene expression for OK+LS was
roughly similar to that for OSK (Fig. 3D). Specifically, the
ectodermmarkers, Sox13, Sox21 and CryM, and themesoderm
marker, Myh2 were significantly underexpressed. Endoderm
marker, Sox17 was highly expressed for OK+LS compared to
OSK. Next, temporal expression was analyzed using qPCR on
days 3, 7 and 16 after infection. The expression ofMyh2, Sox21
and CryM was extremely low for OK+LS compared to OSK on
days 3, 7 and16 after infection. However, no significant
changes were detected for Desmin and Gremlin (Fig. 3E).
These data are supportive that induced cell differentiation into
the ectoderm andmesoderm lineageswas impeded for OK+LS.
Consequently, the decreased generation efficiency of partial
iPSCs contributed to the increased generation efficiency of
fully reprogrammed iPSCs for OK+LS.
Quality of iPSCs generated through OK plus low Sox2
The quality of fully reprogrammed iPSCs that were obtained
using OK+LS was tested. The analyses included examining
the following: colony morphology; uniform Oct4-GFP expres-
sion (Fig. 4A); expression of pluripotent marker genes:
Nanog, Rex1, Stella, Lefty1, Eras, Gdf3, Fgf4, Utf1 and
Sall4 RT-PCR analyses (Fig. 4B); and immunocytochemical
analyses of Nanog, Oct4, Sox2, SSEA-1, Stella, and E-
cadherin (Fig. 4C) in all #1~3 OK+LS-iPSC lines. The resulting
data were indicative that the iPSCs with OK+LS were
comparable to iPSCs with conventional OSK in vitro.
Three LacZ-positive iPSC lines, which have the normal
karyotype 2n=40 and Gtl2 expression (Stadtfeld et al., 2010),
were selected from twenty-two iPSC cell lines that were
examined to determine pluripotency of the OK+LS-iPSCs in
vivo. They were then microinjected into blastocysts. A
contribution to the three germ layers of morphologically
normal E15.5 or E16.5 chimeric embryos was detected by using
X-galactosidase (Gal) staining for all three OK+LS-iPSC lines.
One chimeraout of four embryos for the iPSC line #1, oneout of
eighteen for line #2, and seven out of eleven for line #3 were
determined (Fig. 4D). X-gal-positive germ cells that were
found in the testicular tubules of E16.5 chimeric embryoswere
indicative of the germ cell competence of OK+LS-iPSCs
(Fig. 4D). Therefore, the OK+LS iPSCs were comparable to
conventional iPSCs in terms of pluripotency.
Discussion
A simple method for decreasing Sox2 virus improved the
efficiency of Oct4-GFP-positive cells to emerge for OKM+LS
Figure 3 Expression of pluripotent and lineage marker genes in somatic cells that had been reprogrammed with Oct4, Klf4 (OK) and
low level Sox2 (LS) expression as determined by using quantitative reverse transcription-PCR (qPCR) analysis. (A) Relative expression
of reprogramming factors on day 3 after infection (day 3). The primer sets were designed to amplify both endogenous and transgenic
expressions. n=5. (B-D) The relative expression of Oct4/Sox2 target genes on day 3 (n=5) (B), stem cell markers on day 3 (n=5)
(C), and lineage-specific markers on day 3 (n=5) (D). (E) Kinetic analyses of gene expression relative to MEFs in lineage-specific genes
on days 3, 7, and 16. TE, trophectoderm. * Pb0.05. Error bars, S.E.M.
181Negative effects of excess Sox2 on reprogrammingand OK+LS. This is indicative of the attenuating effects on
the reprogramming efficiency of overexpressed Sox2 for
conventional OKSM and OKS. The increased reprogramming
efficiency for LS resulted from the decreased cell differen-
tiation of MEFs into ectoderm and mesoderm lineages as
observed by using qPCR analyses. The increased number of
GFP-positive cells for OKM+LS was caused by the increase in
partially reprogrammed iPSCs. Improved reprogramming
efficiency of somatic cells into fully reprogrammed iPSCs
was significant for OK+LS. These data are indicative that 1)
the reprogramming efficiency of MEFs into iPSCs was
significantly increased by low level Sox2 expression in a
dose-dependent manner: 2) improved reprogramming effi-ciency for reprogramming into iPSCs by using OK+LS was
associated with impeding cell differentiation of MEFs into
the ectoderm and mesoderm lineages: and 3) the generation
efficiency of partial iPSCs decreased through reprogramming
with OK+LS.
Partial iPSCsweredominantly inducedwithOKM+LS but not
with OK+LS. c-Myc plays a role in controlling the transcription
activity of numerous genes that are related to dedifferentia-
tion andproliferation (Knoepfler, 2008; Sridharan et al., 2009).
The strong transforming activity of c-Myc induces clonal
expansion of the reprogramming cells for OKM+LS (Fig. 5A).
Thus, partial iPSC generation induced with c-Myc masked the
positive effect of LS. In the case of the iPSC induction without
Figure 4 Pluripotency of induced pluripotent stem cells established by using Oct4, Klf4, and low Sox2 (OK+LS-iPSCs). (A) Expression
of Oct4-GFP in morphologically normal OK+LS-iPSCs. GFP expression was detected to be uniform in the cell colonies. (B) Expression
of pluripotent marker genes in #1-3 OK+LS iPSC lines by using RT-PCR. Gapdh was used as a loading control. The primer sets that
were used are summarized in Supplementary Table 1. (C) The expression of pluripotent marker proteins by using immunostaining.
The expression of Nanog, Oct4, Sox2, SSEA1, Stella and E-cadherin (Ecad) was detected as red signals. Nuclei were visualized by using
4’, 6-Diamidino-2-Phenylindole (DAPI). (D) Contribution of OK+LS- iPSCs derivatives in mouse E15.5 or E16.5 chimeric embryos. The
iPSC derivatives were visualized as blue cells by using X-gal staining. Germ cells derived from iPSCs were detected as X-gal-positive
cells in the testis of E15.5 #3 embryo (right panel).
182 S. Yamaguchi et al.c-Myc, the improved effect of LS on the reprogramming
efficiency became more apparent by the excluding the partial
iPSCs (Fig. 5B).
In mice, neural stem cells (NSCs) that express endogenous
Sox2 are successfully reprogrammed into iPSCs only by using
OKM infection (Silva et al., 2008; Eminli et al., 2008).
Interestingly, the reprogramming efficiency of NSCs was
decreased by addition of Sox2 into OKM, such that excessive
Sox2 expression interfered with reprogramming. In humans,
reprogramming efficiency is improved by increasing the
amount of Oct4-expressing lentivirus three-fold (Papapetrouet al., 2009). Furthermore, increased Sox2 virus down-
regulated the efficiency of colony formation, while de-
creased Sox2 enhanced this efficiency. Exogenous Sox2
expression is essential for acquiring pluripotency among
somatic cells through reprogramming in humans and mice
(Takahashi and Yamanaka, 2006; Lowry et al., 2008). These
data are consistent with our findings. Thus, an appropriate
level of Sox2 expression is important to induce the efficient
reprogramming.
Sox2 plays an essential role in mouse development. For
example, it is involved in patterning of the anterior foregut,
Figure 5 Schematic representation of the reprogramming effects of Sox2 at the low expression level (LS) with and without c-Myc on
cell fate. (A) The reprogramming effect of Oct4, Klf4, c-Myc (OKM) and LS on cell fate. For conventional OSKM, the majority of
transduction-mediated reprogramming cells undergo differentiation to ectoderm and mesoderm lineages. A limited number of cells
are changed into fully reprogrammed induced pluripotent stem cells (iPSCs). For OKM and LS, the limited number of cells underwent
differentiation into the ectoderm and mesoderm lineage, while the number of partially reprogrammed iPSCs significantly increased
compared to the OSKM. Furthermore, no increase in the number of fully reprogrammed iPSCs was detected. (B) The reprogramming
effects of Oct4, Klf4 (OK) and LS on cell fate. For conventional OSK, a number of infected cells do not reprogram or differentiate into
the ectoderm and mesoderm lineages. However, a limited number of cells are changed into fully reprogrammed iPSCs. For OK and LS,
the number of fully reprogrammed cells significantly increases instead of there being a decrease in the number of cells that
differentiate into the ectoderm and mesoderm lineages.
183Negative effects of excess Sox2 on reprogrammingmaintaining postnatal NSCs, neurogenesis in the brain, and the
eye formation (Pevny and Nicolis, 2010; Que et al., 2007;
Taranova et al., 2006). Interestingly, Sox2 functions in a dose-
dependent manner in vivo. In the endoderm, the region that
highly expresses Sox2 differentiates into the pharynx and
esophagus. In the region where it is underexpressed, it
becomes the trachea (Que et al., 2007). In the ectoderm,
the heterozygotic loss of Sox2 does not induced an obvious
phenotype. However, a b40% reduction in Sox2 induces
aberrant neural progenitor differentiation, which results in
microphthalmia (Taranova et al., 2006). Thus, Sox2 plays a key
role in differentiation into the ectoderm, mesoderm and
endoderm lineages in a dose-dependent manner in vivo. It
seems that dose-dependent effects of Sox2 are common for in
vivodevelopment and in vitro reprogramming. However, a few
changes in endoderm-related gene expression were detected
for OKM+LS and OK+LS. In ESCs, forced up-regulation of Sox2
results in no significant changes in the expression of endoderm-
related genes (Kopp et al., 2008). This is suggestive that a
dose-dependent effect of Sox2 on the induction of endoderm
lineage differentiation may not be obvious for direct repro-
gramming in vitro.The molecular mechanisms that are involved in inducing
of alternative cell fates by increasing and reducing the
amount of Sox2 during reprogramming remain unclear. An
interesting finding was that Oct4 changes its partner and
targets genes in a dose-dependent manner in human ESCs
(Stefanovic et al., 2009). Excessive expression of Oct4 in
human ESCs leads to differentiation into a cardiac cells
through switching of the binding element that is located to
Sox17 from the Sox2 promoter. It is possible that switching
protein interaction partners and binding affinity to regula-
tory elements of downstream genes, which changes cell fate,
occurs in Sox2 in a dose-dependent manner, similar to that of
Oct4. The qPCR analyses that are discussed here were
evaluated using RNA that was extracted from heterogeneous
populations through reprogramming that was induced using
defined factors. Further comparisons of expression profiles
between colonies could be helpful for understanding the
molecular events that underlie the dose-dependent effect of
Sox2.
We conclude that the significantly increased generation
efficiency of fully reprogrammed iPSCs via OK+LS resulted
from efficient reprogramming into fully reprogramming
184 S. Yamaguchi et al.iPSCs following a significant increase in Oct4-GFP-positive
iPSCs. Optimizing the dose of reprogramming factors will be
a key to realizing practical applications of recently devel-
oped integration-free and genetic modification-free repro-
gramming technologies.Materials and methods
Cell culture
Mouse iPSCs or ESCs were maintained in DMEM/F12 (Dulbec-
co's modified Eagle's medium/Ham's F12, Wako Chemical,
Osaka, Japan), which was supplemented with 15% fetal
bovine serum (FBS; Gibco, Carlsbad, CA), 10-4 M 2-mercap-
toethanol, and 400 units/ml recombinant LIF (Chemicon,
Temecula, MA). The cells were maintained on MEFs feeder
cells that had been inactivated with mitomycin C. To isolate
double-transgenic MEFs, E12.5 embryos were minced with
an 18-gauge needle after being obtained fromGOD-18/delta
PE/GFP (Oct4-GFP) transgenic females (Yoshimizu et al.,
1999) that had been mated with 129/Rosa26 transgenic
males (Friedrich and Soriano, 1991). The resulting cell
suspension was plated and cultured with DMEM (Sigma
Aldrich, St. Louis, MO) containing 10% FBS. MEFs were used
during early passages.iPSC induction from MEFs
Retroviral supernatants for Oct4, Sox2, Klf4 and c-Myc were
collected from PlatE packaging cells and stored at –80 °C
prior to being used for infection. Titers for Oct4 and Sox2 but
not Klf4 and c-Myc virus were determined by using immuno-
cytochemical analyses of MEFs at 36 hours after infection.
Oct4 and Sox2 virus were used at the same multiplicity of
infection (MOI) of 3 for OSKM or OSK transduction. MEFs were
seeded on gelatin-coated 12-well culture plates at 4 x 104
cells per well, and were infected with a mixture of stocked
viral supernatant with 4 μg/mL polybrene (day 0) to
determine the reprogramming efficiency. The medium was
replaced with ESCmedium on day 1. All GFP-positive colonies
in each well were counted among days 4-12 for OSKM, and
days 6-16 for OSK. Infected cells were reseeded on a feeder
layer on day 4 and picked up on day 14 for OSKM or day 20 for
OSK, to establish iPSCs.Western blot hybridization
Whole cell lysate was extracted from MEFs on day 3 after
infection. Total protein (5 μg) was separated by using10%
SDS-polyacrylamide gel electrophoresis and transferred onto
a nitrocellulose membrane (Millipore, Billerica, MA). It was
subsequently reacted with anti-Oct4 (1:100 dilution), anti-
Sox2 (1:2000), or anti-beta-actin (1:2000) antibodies at 4 °C
overnight. The membranes were then incubated with a
secondary antibody (1/3000; GE Healthcare, Little Chalfont,
Buckinghamshire, U.K.) for one hour and the signals were
then detected by using the ECL Western blotting detection
kit (GE Healthcare).Immunocytochemistry
Cells that were fixed with 4% paraformaldehyde in phos-
phate-buffered saline (PBS) for 15 minutes at room temper-
ature were pre-treated with blocking solution at 4 °C
overnight. The blocking solution was composed of PBS
containing 3% BSA (Sigma), 2% skim milk (DIFCO, Detroit,
MI), and 0.1% Triton X-100. The cells were then stained with
fluorescence-conjugated secondary antibody (1/500; Invi-
trogen), following to immunoreaction with anti-Oct4 (1:50),
anti-Nanog (1:1000), anti-Sox2 (1:1000), anti-Stella (1:500),
anti-SSEA1 (1/1000), or anti-E-Cadherin (1/1000) at 4 °C
overnight.Mouse chimeric embryos
OKM+LS- and OK+LS-iPSCs were microinjected into C57BL/
6J or (C57BL/6JxBDA)F2 blastocysts and then transferred
into the uteruses of pseudo-pregnant ICR females. E12.5,
E15.5 and E16.5 embryos were collected and stained
according to X-Gal staining procedures (Tada et al., 1997).Flow Cytometry
Cells were dissociated into single cells with 0.25% trypsin/
0.4% EDTA/ PBS, washed once, re-suspended in PBS with 2%
FBS, and analyzed using a FACS Vantage system (Becton
Dickinson, Franklin Lakes, NJ).Quantitative reverse transcription-PCR (qPCR)
Total RNA was extracted using TRIzol (Invitrogen, Carlsbad,
CA) according to the manufacturer's instructions. DNase I
(Roche Diagnostics, Basel, Switzerland)-treated RNA was
reverse-transcribed by using random primers and Superscript
III Reverse Transcriptase (Invitrogen). Amplification was
performed using the Prism 7700 (Applied Biosystems, Foster
City, CA) and Power SYBR Green PCR Master Mix (Applied
Biosystems) according to the manufacturer's instructions
with gene-specific primer sets. All reactions were carried out
in duplicate and gene expression levels were normalized to
Gapdh. Relative expression of each gene was quantified from
threshold cycles for amplification using the 2ΔΔCt method.
The primer sets that were used are summarized in
Supplementary Table 1.Acknowledgments
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